Helping Employers with Tobacco and Vaping Cessation in Response to COVID-19

News & Updates
1 min read
Yusuf Sherwani

Dr. Yusuf Sherwani MD

CEO and Co-founder at Pelago

As the world comes together to contain the spread of the COVID-19 pandemic, governments and employers are recognizing the important role digital health is playing in minimizing exposure whilst delivering continuity of care. 

As a physician-led company, we feel compelled to do our part to contain the spread and help those most at risk. We also recognize that Quit Genius is a life-saving program for those most vulnerable to COVID-19.

A recent report from the World Health Organization (WHO) suggests that smokers have an increased susceptibility to COVID-19 and are more at risk of developing serious lung disease.

“Smokers are at high risk for heart disease and respiratory disease, which are high-risk factors for developing the severe or critical disease with COVID-19,” says Dr Paranie, WHO Representative.

Quit Genius is the leading digital therapeutic program for tobacco and vaping cessation offering members access to evidence-based coaching, wearable technology and medication to quit smoking and vaping for good. 

We have made the decision to offer employers access to our industry-leading program at no cost for members signing up in March and April 2020. 

Moreover, our client success team has committed to speed up implementation and start rolling Quit Genius out to your members within 48 hours.

To request access, simply complete the form below and a member of our team will be in touch. 

Say hello to brighter days together

Get started quickly. Save costs. Change lives forever.